Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia

von Shima, Midori
Veröffentlicht in Res Pract Thromb Haemost (2020)

Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan

von Tomioka, Kimiko, Shima, Midori, Saeki, Keigo
Veröffentlicht in Harm Reduct J (2021)

Questionnaire survey on maternal pertussis vaccination for pregnant women and mothers in Nara prefecture, Japan

von Kitano, Taito, Onishi, Tomoko, Takeyama, Masahiro, Shima, Midori
Veröffentlicht in Hum Vaccin Immunother (2019)

Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review

von Imashuku, Shinsaku, Hasegawa, Takeshi, Kubo, Kagekatsu, Nakato, Masaki, Shima, Midori
Veröffentlicht 2011

Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B

von Marlar, Richard A., Strandberg, Karin, Shima, Midori, Adcock, Dorothy M.
Veröffentlicht in Eur J Haematol (2019)

Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A

von Oh, Jisu, Lim, Yeongmin, Jang, Moon Ju, Huh, Ji Young, Shima, Midori, Oh, Doyeun
Veröffentlicht 2013

Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells

von Sakurai, Yoshihiko, Kasuda, Shogo, Tatsumi, Kohei, Takeda, Tomohiro, Kato, Junko, Kubo, Atsushi, Shima, Midori
Veröffentlicht 2013

A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A

von Tatsumi, Kohei, Sugimoto, Mitsuhiko, Lillicrap, David, Shima, Midori, Ohashi, Kazuo, Okano, Teruo, Matsui, Hideto
Veröffentlicht 2013

Membranous nephropathy with acquired factor V inhibitor: a case report

von Kitamura, Shinji, Misawa, Mahito, Namba, Sayaka, Tsuji, Kenji, Torigoe, Rikako, Shima, Midori, Makino, Hirofumi
Veröffentlicht 2013

A first-in-human phase 1 study of ACE910, a novel factor VIII–mimetic bispecific antibody, in healthy subjects

von Uchida, Naoki, Sambe, Takehiko, Yoneyama, Koichiro, Fukazawa, Naoki, Kawanishi, Takehiko, Kobayashi, Shinichi, Shima, Midori
Veröffentlicht in Blood (2016)

Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio

von Kobayashi, Ryohei, Hasegawa, Mari, Kawaguchi, Chiharu, Ishikawa, Naoko, Tomiwa, Kiyotaka, Shima, Midori, Nogami, Keiji
Veröffentlicht in Clin Pediatr Endocrinol (2021)

Identification of Plasmin-interactive Sites in the Light Chain of Factor VIII Responsible for Proteolytic Cleavage at Lys(36)

von Nogami, Keiji, Nishiya, Katsumi, Saenko, Evgueni L., Takeyama, Masahiro, Ogiwara, Kenichi, Yoshioka, Akira, Shima, Midori
Veröffentlicht 2009

Effects on coagulation factor production following primary hepatomitogen-induced direct hyperplasia

von Tatsumi, Kohei, Ohashi, Kazuo, Taminishi, Sanae, Takagi, Soichi, Utoh, Rie, Yoshioka, Akira, Shima, Midori, Okano, Teruo
Veröffentlicht 2009

Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein κ-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody

von Hara, Yoshitaka, Makita, Masanori, Ishikawa, Tatsunori, Saeki, Kyosuke, Yamamoto, Kazuhiko, Imajo, Kenji, Shima, Midori, Ieko, Masahiro
Veröffentlicht 2012

Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A

von Matsui, Hideto, Fujimoto, Naoko, Sasakawa, Noriko, Ohinata, Yasuhide, Shima, Midori, Yamanaka, Shinya, Sugimoto, Mitsuhiko, Hotta, Akitsu
Veröffentlicht 2014

Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture

von Kasuda, Shogo, Matsui, Hideto, Ono, Shiro, Matsunari, Yasunori, Nishio, Kenji, Shima, Midori, Hatake, Katsuhiko, Sugimoto, Mitsuhiko
Veröffentlicht in Haematologica (2016)

Hepatocyte Is a Sole Cell Type Responsible for the Production of Coagulation Factor IX In Vivo

von Tatsumi, Kohei, Ohashi, Kazuo, Mukobata, Shigeki, Kubo, Atsushi, Koyama, Fumikazu, Nakajima, Yoshiyuki, Shima, Midori, Okano, Teruo
Veröffentlicht in Cell Med (2012)

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

von Shima, Midori, Nogami, Keiji, Nagami, Sayaka, Yoshida, Seitaro, Yoneyama, Koichiro, Ishiguro, Akira, Suzuki, Takashi, Taki, Masashi
Veröffentlicht in Haemophilia (2019)

A thromboembolic mechanism in bow hunter's stroke: Importance of hemodynamic evaluation by ultrasonography during head rotation

von Eura, Nobuyuki, Saito, Kozue, Shimizu, Hironori, Takeshima, Yasuhiro, Shima, Midori, Kichikawa, Kimihiko, Nakase, Hiroyuki, Sugie, Kazuma
Veröffentlicht in eNeurologicalSci (2020)

A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A

von Yoneyama, Koichiro, Schmitt, Christophe, Kotani, Naoki, Levy, Gallia G., Kasai, Ryu, Iida, Satofumi, Shima, Midori, Kawanishi, Takehiko
Veröffentlicht in Clin Pharmacokinet (2017)